New Delhi, July 9: Using a combination of sodium-glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection agains… [+1732 chars]
Study shows how to protect diabetics from heart, kidney disease - Greater Kashmir
